Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Mitotax 110mg Injection

Prescription Icon
Prescription Required

Marketer

Dr Reddy's Laboratories Ltd

Salt Composition

Paclitaxel (110mg)

Overview Mitotax 110mg Injection

Oncaspare, a 110mg injectable anticancer agent, treats breast, pancreatic, and non-small cell lung cancers. Administered intravenously by healthcare professionals, dosage and frequency are determined by your physician based on your specific condition and may vary. Strictly adhere to your doctor's prescribed regimen; incorrect usage or overdose can cause severe adverse reactions. Therapeutic effects might not be apparent for weeks or months; discontinue use only under medical supervision. Common side effects include nausea, vomiting, and fatigue. Serious side effects such as edema (swelling of hands and face), alopecia (hair loss), and weight gain are possible. Concomitant medications may mitigate these effects. Report unusual bruising, bleeding, sore throat, mouth sores, or fever immediately. This medication can lower blood cell counts (red and white), increasing infection risk, necessitating regular blood tests to monitor blood cell levels and liver function. Prior to treatment, inform your doctor of any pre-existing heart, liver, or kidney conditions, or concurrent use of anti-infective medications. Interactions with other drugs are possible; disclose all medications you are taking. This medication is contraindicated during pregnancy and breastfeeding; effective contraception for both partners is crucial throughout treatment.

Primary Ingredients of Mitotax 110mg Injection

No text provided. Please provide the text you want me to rephrase.

Uses of Mitotax 110mg Injection

Cancers of the breast, lung (non-small cell type), and pancreas

Major Benefits of Mitotax 110mg Injection:

The medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

Common Side effects of Mitotax 110mg Injection:

  • Nausea
  • Vomiting
  • Weakness
  • Low blood platelets
  • Rash
  • Upper respiratory tract infection
  • Urinary tract infection
  • Bleeding
  • Anemia (low number of red blood cells)
  • Flushing (sense of warmth in the face, ears, neck and trunk)
  • Hair loss
  • Decreased blood pressure
  • Peripheral neuropathy (tingling and numbness of feet and hand)
  • Diarrhea
  • Decreased white blood cell count (neutrophils)

How to use Mitotax 110mg Injection:

This medication will be administered by your healthcare provider; self-medication is strictly prohibited.

How Mitotax 110mg Injection works:

Mitotax 110mg Injection is a cancer treatment that disrupts the microtubule networks essential for cancer cell division and proliferation. This action inhibits tumor growth, leading to the death of cancer cells.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while using Mitotax 110mg Injection is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Administering Mitotax 110mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.

Breast feedingBreast feedingUNSAFE

Administering Mitotax 110mg Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingUNSAFE

Administering Mitotax 110mg Injection might induce adverse reactions impacting driving capabilities. While continued driving between treatment cycles isn't inherently prohibited, the injection's alcohol content suggests caution regarding driving.

KidneyKidneySAFE IF PRESCRIBED

Mitotax 110mg Injection can be administered to patients with kidney disease without dosage modification. Nevertheless, patients with pre-existing kidney conditions should consult their physician before use.

LiverLiverCAUTION

Individuals with liver impairment should use Mitotax 110mg Injection cautiously, potentially requiring dosage modification. Medical advice is essential. Mitotax 110mg Injection is contraindicated in patients exhibiting severe hepatic dysfunction.

What if you forget to take Mitotax 110mg Injection :

NA

Facts to Know About Mitotax 110mg Injection

LabelValue
Chemical Category Taxane-Based Drugs
Developing Habits No.
Treatment Category Cancer Medications
Actions Taxanes: Antimicrotubule Agents

FAQs on Mitotax 110mg Injection

Mitotax 110mg Injection is an FDA-approved, cytotoxic taxane.
Mitotax 110mg Injection can be irritating to tissues.
Mitotax 110mg Injection is photosensitive, hydrophobic, and cardiotoxic.
Hair loss is a possible side effect of Mitotax 110mg Injection. Report any side effects to your doctor during treatment.
Mitotax 110mg Injection is extracted from the Pacific yew tree, *Taxus brevifolia*.
Mitotax 110mg Injection
2,681
MRP 3,266
17% off